← Eichor
Study identifier: NCT04613596 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Condition: Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer  ·  Sponsor: Mirati Therapeutics Inc.

PhasePhase 2/Phase 3
Planned participants626
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study compares the efficacy of adagrasib in combination with pembrolizumab versus pembrolizumab in patients with unresectable, locally advanced or metastatic squamous or nonsquamous NSCLC with KRAS G12C mutation and PD-L1 TPS \>=50% and who are candidates for first line treatment.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (770)

Local Institution - 007-556-AGoodyear, Arizona, United StatesNot Yet Recruiting
USOR - Arizona Oncology - Prescott ValleyPrescott Valley, Arizona, United StatesRecruiting
Local Institution - 007-568-ASafford, Arizona, United StatesNot Yet Recruiting
Local Institution - 007-568-BSafford, Arizona, United StatesNot Yet Recruiting
Local Institution - 007-568-CSafford, Arizona, United StatesNot Yet Recruiting
Local Institution - 007-568-DSafford, Arizona, United StatesNot Yet Recruiting
Local Institution - 007-568-ESafford, Arizona, United StatesNot Yet Recruiting
Arizona Clinical Research CenterTucson, Arizona, United StatesRecruiting
Highlands Oncology Group - SpringdaleSpringdale, Arkansas, United StatesRecruiting
Providence - Saint Joseph Home Health - AnaheimAnaheim, California, United StatesRecruiting
The Oncology Institute of Hope and Innovation - Corporate OfficeCerritos, California, United StatesRecruiting
Local Institution - 007-777Fountain Valley, California, United StatesNot Yet Recruiting

+ 758 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04613596